Skip to content

Distal embolisation during percutaneous coronary intervention - evaluation of contributory factors and analysis of embolic material

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86339277
Enrollment
100
Registered
2003-09-12
Start date
2002-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular: Distal embolisation Circulatory System Distal embolisation

Interventions

Use of Symbiot self-expanding stent or a conventional stent.

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing PCI (percutaneous coronary intervention) to saphenous vein grafts. 2. Patients undergoing PCI for an acute coronary syndrome. =15 mm length of vessel beyond lesion and before graft insertion or major side-branch of native vessel to allow placement of filter wire.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Primary endpoint: amount of distal embolisation determined by weight of material collected in distal protection device.

Secondary

MeasureTime frame
Secondary endpoints: 1. Troponin I at 12 h 2. Analysis of debris collected within distal protection device

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026